Demand growing for female condoms despite myths

Published on November 15, 2012 at 4:48 AM · No Comments

Mary Beth Hastings, vice president of the Center for Health and Gender Equality (CHANGE), writes in the Huffington Post's "Impact" blog that despite "the pervasive myth that no one wants female condoms," "[d]emand is increasing because female condoms provide men and women with something they want: more options when it comes to protecting themselves." USAID officials "were surprised to hear evidence of an unmet demand for female condoms," Hastings says, adding, "[W]hen presented with evidence to the contrary, USAID started talking with different institutions about meeting the demand." She continues, "To its credit, the U.S. government is a global leader on female condoms. But there is still room for improvement."

Hastings says U.S.-funded HIV prevention and family planning programs "should all include education about and access to female condoms." She adds, "Female condoms are an opportunity to promote women's rights as much as they are an opportunity to fight HIV, because they can and they do generate important conversations within couples and communities about love, protection, trust and power," and concludes, "That's what makes them so special, and so worthy of investment" (11/13).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Posted in: Women's Health News | Disease/Infection News

Tags: , , ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
BIDMC receives $20 million grant to evaluate, test monoclonal antibodies for HIV treatment